BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22016254)

  • 1. Effect of estrogen replacement therapy on symptoms of depression and anxiety in non-depressive menopausal women: a randomized double-blind, controlled study.
    Demetrio FN; Rennó J; Gianfaldoni A; Gonçalves M; Halbe HW; Filho AH; Gorenstein C
    Arch Womens Ment Health; 2011 Dec; 14(6):479-86. PubMed ID: 22016254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life.
    Almeida OP; Lautenschlager NT; Vasikaran S; Leedman P; Gelavis A; Flicker L
    Neurobiol Aging; 2006 Jan; 27(1):141-9. PubMed ID: 16298249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women.
    Haines CJ; Yim SF; Chung TK; Lam CW; Lau EW; Ng MH; Chin R; Lee DT
    Maturitas; 2003 Mar; 44(3):207-14. PubMed ID: 12648884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the effects of estradiol or estradiol/progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healthy hysterectomized women: a questionnaire study.
    Heinrich AB; Wolf OT
    Neuropsychobiology; 2005; 52(1):17-23. PubMed ID: 15942259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial.
    Diem SJ; Guthrie KA; Mitchell CM; Reed SD; Larson JC; Ensrud KE; LaCroix AZ
    Menopause; 2018 Oct; 25(10):1086-1093. PubMed ID: 29738424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures.
    Bech P; Munk-Jensen N; Obel EB; Ulrich LG; Eiken P; Nielsen SP
    Psychother Psychosom; 1998; 67(4-5):259-65. PubMed ID: 9693354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy.
    Savolainen-Peltonen H; Hautamäki H; Tuomikoski P; Ylikorkala O; Mikkola TS
    Menopause; 2014 Jul; 21(7):732-9. PubMed ID: 24219882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study.
    Nielsen TF; Ravn P; Pitkin J; Christiansen C
    Maturitas; 2006 Jan; 53(2):184-90. PubMed ID: 16368471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen improves psychological function in asymptomatic postmenopausal women.
    Ditkoff EC; Crary WG; Cristo M; Lobo RA
    Obstet Gynecol; 1991 Dec; 78(6):991-5. PubMed ID: 1658700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.
    Soares CN; Almeida OP; Joffe H; Cohen LS
    Arch Gen Psychiatry; 2001 Jun; 58(6):529-34. PubMed ID: 11386980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial.
    Arrenbrecht S; Boermans AJ
    Osteoporos Int; 2002; 13(2):176-83. PubMed ID: 11908492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood disorders in midlife women: understanding the critical window and its clinical implications.
    Soares CN
    Menopause; 2014 Feb; 21(2):198-206. PubMed ID: 24448106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women.
    Kornstein SG; Clayton AH; Bao W; Guico-Pabia CJ
    J Womens Health (Larchmt); 2015 Apr; 24(4):281-90. PubMed ID: 25860107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial.
    Gordon JL; Rubinow DR; Eisenlohr-Moul TA; Xia K; Schmidt PJ; Girdler SS
    JAMA Psychiatry; 2018 Feb; 75(2):149-157. PubMed ID: 29322164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen replacement therapy and cognitive functions in healthy postmenopausal women: a randomized trial.
    Gorenstein C; Rennó J; Vieira Filho AH; Gianfaldoni A; Gonçalves MA; Halbe HW; Fernandes CE; Demétrio FN
    Arch Womens Ment Health; 2011 Oct; 14(5):367-73. PubMed ID: 21732218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo.
    Kwee SH; Tan HH; Marsman A; Wauters C
    Maturitas; 2007 Sep; 58(1):83-90. PubMed ID: 17689896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of tibolone and transdermal estrogen therapy on psychological symptoms in women following surgical menopause.
    Baksu A; Ayas B; Citak S; Kalan A; Baksu B; Goker N
    Int J Gynaecol Obstet; 2005 Oct; 91(1):58-62. PubMed ID: 15970290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms.
    Cheng RJ; Dupont C; Archer DF; Bao W; Racketa J; Constantine G; Pickar JH
    Climacteric; 2013 Feb; 16(1):17-27. PubMed ID: 22646219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.